Pharmozyme currently specializes in a new and improved one-step SARS-COV-2 one step RT-qPCR detection Kit for the detection of SARS-CoV-2(2019-nCoV) viral RNA by targeting the E & N2 genes. A rapid molecular diagnostic tool to detect SARS-CoV-2 causing Covid-19 in patients.
Founded in 2013, Co-founder Dr. Nader Nourizad, A pioneer in pyrosequencing and reagent engineering, believed the market was in desperate need of high quality, high yield, and above all else, truly pure reagents.
Pharmozyme has since developed proprietary technology to produce the world’s purest reagents, introducing the world’s first Taq Polymerase free from bacterial and animal DNA contamination. In the coming years Pharmozyme plans to release a variety of contamination free reagents, supporting new technologies in sequencing and DNA research. Its future path will include the production of highly accurate and sensitive kits for medical diagnostics.
Pharmozyme’s mission is to significantly improve the lives of human beings through the development of novel, effective, and accessible solutions for the biotech community.
Pharmozyme Address
1190 Mountain View Alviso Rd. Sunnyvale, CA United States